Cargando…
Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway
Synovial macrophage polarization and inflammation are essential for osteoarthritis (OA) development, yet the molecular mechanisms and regulation responsible for the pathogenesis are still poorly understood. Here, we report that pseudolaric acid B (PAB) attenuated articular cartilage degeneration and...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278075/ https://www.ncbi.nlm.nih.gov/pubmed/34117708 http://dx.doi.org/10.1111/jcmm.16670 |
_version_ | 1783722191249997824 |
---|---|
author | Lu, Jiansen Guan, Hong Wu, Dan Hu, Zhiqiang Zhang, Hongbo Jiang, Huaji Yu, Jingyao Zeng, Ke Li, Hongyu Zhang, Haiyan Pan, Chenglong Cai, Daozhang Yu, Xiao |
author_facet | Lu, Jiansen Guan, Hong Wu, Dan Hu, Zhiqiang Zhang, Hongbo Jiang, Huaji Yu, Jingyao Zeng, Ke Li, Hongyu Zhang, Haiyan Pan, Chenglong Cai, Daozhang Yu, Xiao |
author_sort | Lu, Jiansen |
collection | PubMed |
description | Synovial macrophage polarization and inflammation are essential for osteoarthritis (OA) development, yet the molecular mechanisms and regulation responsible for the pathogenesis are still poorly understood. Here, we report that pseudolaric acid B (PAB) attenuated articular cartilage degeneration and synovitis during OA. PAB, a diterpene acid, specifically inhibited NF‐κB signalling and reduced the production of pro‐inflammatory cytokines, which further decreased M1 polarization and vessel formation. We further provide in vivo and in vitro evidences that PAB suppressed NF‐κB signalling by stabilizing PPARγ. Using PPARγ antagonist could abolish anti‐inflammatory effect of PAB and rescue the activation of NF‐κB signalling during OA. Our findings identify a previously unrecognized role of PAB in the regulation of OA and provide mechanisms by which PAB regulates NF‐κB signalling through PPARγ, which further suggest targeting synovial inflammation or inhibiting vessel formation at early stage could be an effective preventive strategy for OA. |
format | Online Article Text |
id | pubmed-8278075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82780752021-07-15 Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway Lu, Jiansen Guan, Hong Wu, Dan Hu, Zhiqiang Zhang, Hongbo Jiang, Huaji Yu, Jingyao Zeng, Ke Li, Hongyu Zhang, Haiyan Pan, Chenglong Cai, Daozhang Yu, Xiao J Cell Mol Med Original Articles Synovial macrophage polarization and inflammation are essential for osteoarthritis (OA) development, yet the molecular mechanisms and regulation responsible for the pathogenesis are still poorly understood. Here, we report that pseudolaric acid B (PAB) attenuated articular cartilage degeneration and synovitis during OA. PAB, a diterpene acid, specifically inhibited NF‐κB signalling and reduced the production of pro‐inflammatory cytokines, which further decreased M1 polarization and vessel formation. We further provide in vivo and in vitro evidences that PAB suppressed NF‐κB signalling by stabilizing PPARγ. Using PPARγ antagonist could abolish anti‐inflammatory effect of PAB and rescue the activation of NF‐κB signalling during OA. Our findings identify a previously unrecognized role of PAB in the regulation of OA and provide mechanisms by which PAB regulates NF‐κB signalling through PPARγ, which further suggest targeting synovial inflammation or inhibiting vessel formation at early stage could be an effective preventive strategy for OA. John Wiley and Sons Inc. 2021-06-11 2021-07 /pmc/articles/PMC8278075/ /pubmed/34117708 http://dx.doi.org/10.1111/jcmm.16670 Text en © 2021 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Lu, Jiansen Guan, Hong Wu, Dan Hu, Zhiqiang Zhang, Hongbo Jiang, Huaji Yu, Jingyao Zeng, Ke Li, Hongyu Zhang, Haiyan Pan, Chenglong Cai, Daozhang Yu, Xiao Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway |
title | Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway |
title_full | Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway |
title_fullStr | Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway |
title_full_unstemmed | Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway |
title_short | Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF‐κB signalling pathway |
title_sort | pseudolaric acid b ameliorates synovial inflammation and vessel formation by stabilizing pparγ to inhibit nf‐κb signalling pathway |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278075/ https://www.ncbi.nlm.nih.gov/pubmed/34117708 http://dx.doi.org/10.1111/jcmm.16670 |
work_keys_str_mv | AT lujiansen pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway AT guanhong pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway AT wudan pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway AT huzhiqiang pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway AT zhanghongbo pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway AT jianghuaji pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway AT yujingyao pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway AT zengke pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway AT lihongyu pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway AT zhanghaiyan pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway AT panchenglong pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway AT caidaozhang pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway AT yuxiao pseudolaricacidbamelioratessynovialinflammationandvesselformationbystabilizingppargtoinhibitnfkbsignallingpathway |